Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 40 | 2024 | 2038 | 4.900 |
Why?
|
Coronary Artery Disease | 34 | 2024 | 6456 | 4.820 |
Why?
|
Acute Coronary Syndrome | 22 | 2024 | 2334 | 4.250 |
Why?
|
Drug-Eluting Stents | 9 | 2024 | 755 | 4.020 |
Why?
|
Heart Valve Prosthesis Implantation | 26 | 2024 | 1574 | 3.600 |
Why?
|
Atrial Fibrillation | 17 | 2024 | 5050 | 2.360 |
Why?
|
Fibrinolytic Agents | 10 | 2023 | 2136 | 2.280 |
Why?
|
Coronary Artery Bypass | 11 | 2023 | 2247 | 2.250 |
Why?
|
Thrombosis | 9 | 2023 | 3000 | 2.240 |
Why?
|
Ultrasonography, Interventional | 10 | 2024 | 1478 | 2.240 |
Why?
|
Platelet Aggregation Inhibitors | 18 | 2023 | 3118 | 2.210 |
Why?
|
Treatment Outcome | 118 | 2024 | 63664 | 2.210 |
Why?
|
Aortic Valve | 34 | 2024 | 1972 | 2.170 |
Why?
|
Hospital Mortality | 32 | 2023 | 5215 | 2.100 |
Why?
|
Ventricular Dysfunction, Left | 9 | 2023 | 2058 | 2.060 |
Why?
|
Acute Kidney Injury | 9 | 2024 | 1841 | 1.970 |
Why?
|
Endovascular Procedures | 10 | 2024 | 2030 | 1.960 |
Why?
|
Heart Failure | 24 | 2024 | 11085 | 1.930 |
Why?
|
Heart Valve Prosthesis | 13 | 2023 | 1495 | 1.900 |
Why?
|
Randomized Controlled Trials as Topic | 38 | 2024 | 10095 | 1.870 |
Why?
|
Myocardial Infarction | 16 | 2024 | 11655 | 1.820 |
Why?
|
Renal Dialysis | 7 | 2022 | 1692 | 1.700 |
Why?
|
Anticoagulants | 13 | 2023 | 4732 | 1.670 |
Why?
|
Heart-Assist Devices | 11 | 2024 | 1243 | 1.650 |
Why?
|
Mitral Valve Insufficiency | 10 | 2024 | 1404 | 1.620 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2023 | 1396 | 1.580 |
Why?
|
Cardiac Valve Annuloplasty | 2 | 2022 | 50 | 1.520 |
Why?
|
Humans | 273 | 2024 | 746070 | 1.460 |
Why?
|
Coronary Angiography | 20 | 2024 | 4514 | 1.410 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 3 | 2021 | 535 | 1.410 |
Why?
|
Out-of-Hospital Cardiac Arrest | 3 | 2023 | 342 | 1.410 |
Why?
|
Pulmonary Embolism | 5 | 2023 | 2499 | 1.380 |
Why?
|
Stroke | 20 | 2024 | 9692 | 1.370 |
Why?
|
New York City | 8 | 2022 | 706 | 1.260 |
Why?
|
Peripheral Arterial Disease | 8 | 2023 | 1255 | 1.250 |
Why?
|
Postoperative Complications | 23 | 2024 | 15341 | 1.240 |
Why?
|
Angioplasty, Balloon, Coronary | 5 | 2020 | 1866 | 1.240 |
Why?
|
Hypertension, Pulmonary | 3 | 2023 | 1541 | 1.240 |
Why?
|
Saphenous Vein | 2 | 2021 | 523 | 1.220 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2023 | 991 | 1.200 |
Why?
|
Stroke Volume | 14 | 2023 | 5139 | 1.170 |
Why?
|
Hemorrhage | 20 | 2023 | 3522 | 1.170 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2022 | 353 | 1.160 |
Why?
|
Risk Factors | 77 | 2024 | 72413 | 1.140 |
Why?
|
Alanine | 4 | 2023 | 581 | 1.130 |
Why?
|
Intra-Aortic Balloon Pumping | 4 | 2024 | 222 | 1.110 |
Why?
|
Shock, Cardiogenic | 8 | 2024 | 699 | 1.110 |
Why?
|
Hemoglobins | 3 | 2021 | 1510 | 1.080 |
Why?
|
Thrombolytic Therapy | 5 | 2023 | 2072 | 1.080 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2024 | 2190 | 1.070 |
Why?
|
Purinergic P2Y Receptor Antagonists | 5 | 2023 | 374 | 1.060 |
Why?
|
Fractional Flow Reserve, Myocardial | 3 | 2023 | 327 | 0.980 |
Why?
|
Coronary Vessel Anomalies | 3 | 2024 | 313 | 0.970 |
Why?
|
Bioprosthesis | 4 | 2023 | 592 | 0.970 |
Why?
|
Adenosine Monophosphate | 3 | 2021 | 265 | 0.970 |
Why?
|
Coronavirus Infections | 6 | 2021 | 3054 | 0.950 |
Why?
|
Steroids | 4 | 2021 | 919 | 0.940 |
Why?
|
Retrospective Studies | 63 | 2024 | 78293 | 0.930 |
Why?
|
Patient Readmission | 13 | 2023 | 3170 | 0.930 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2021 | 1508 | 0.920 |
Why?
|
Coronary Vessels | 6 | 2022 | 3074 | 0.900 |
Why?
|
Japan | 12 | 2023 | 1267 | 0.890 |
Why?
|
Heart Diseases | 4 | 2020 | 2764 | 0.840 |
Why?
|
Adrenal Cortex Hormones | 2 | 2021 | 1867 | 0.830 |
Why?
|
Registries | 13 | 2023 | 8170 | 0.810 |
Why?
|
Blood Transfusion | 3 | 2024 | 1286 | 0.800 |
Why?
|
Mitral Valve Annuloplasty | 2 | 2024 | 145 | 0.780 |
Why?
|
Heart Transplantation | 10 | 2023 | 3032 | 0.780 |
Why?
|
Nose Diseases | 1 | 2022 | 79 | 0.770 |
Why?
|
Aortic Aneurysm, Abdominal | 6 | 2024 | 1192 | 0.770 |
Why?
|
Blood Vessel Prosthesis Implantation | 4 | 2024 | 1387 | 0.760 |
Why?
|
Aortic Aneurysm, Thoracic | 3 | 2024 | 682 | 0.760 |
Why?
|
Mucormycosis | 1 | 2022 | 99 | 0.750 |
Why?
|
Venous Thromboembolism | 3 | 2023 | 1771 | 0.750 |
Why?
|
Coronary Aneurysm | 1 | 2023 | 231 | 0.740 |
Why?
|
Ischemic Attack, Transient | 2 | 2023 | 895 | 0.730 |
Why?
|
Coronary Restenosis | 1 | 2023 | 426 | 0.730 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3166 | 0.720 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2021 | 962 | 0.720 |
Why?
|
Aortic Rupture | 2 | 2020 | 312 | 0.720 |
Why?
|
Antimetabolites | 1 | 2020 | 127 | 0.700 |
Why?
|
Ablation Techniques | 1 | 2023 | 244 | 0.700 |
Why?
|
Orbital Diseases | 1 | 2022 | 183 | 0.690 |
Why?
|
Catheter Ablation | 3 | 2022 | 2713 | 0.690 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5765 | 0.680 |
Why?
|
Aged | 63 | 2024 | 164222 | 0.680 |
Why?
|
Troponin | 2 | 2020 | 513 | 0.680 |
Why?
|
Troponin I | 2 | 2020 | 623 | 0.670 |
Why?
|
Glucosides | 1 | 2024 | 491 | 0.670 |
Why?
|
Pharmacy | 1 | 2021 | 92 | 0.660 |
Why?
|
Tomography, Optical Coherence | 3 | 2024 | 2805 | 0.660 |
Why?
|
Vitamin K | 4 | 2023 | 311 | 0.650 |
Why?
|
Risk Assessment | 28 | 2024 | 23454 | 0.650 |
Why?
|
Hospitalization | 12 | 2024 | 10327 | 0.640 |
Why?
|
Male | 85 | 2024 | 351098 | 0.640 |
Why?
|
Vascular Diseases | 2 | 2024 | 1162 | 0.620 |
Why?
|
Coated Materials, Biocompatible | 1 | 2020 | 321 | 0.620 |
Why?
|
Inferior Wall Myocardial Infarction | 1 | 2017 | 8 | 0.610 |
Why?
|
Heart Arrest | 3 | 2023 | 1483 | 0.610 |
Why?
|
Stents | 7 | 2024 | 3282 | 0.600 |
Why?
|
Embolism | 1 | 2021 | 405 | 0.600 |
Why?
|
Endarterectomy, Carotid | 1 | 2023 | 547 | 0.600 |
Why?
|
Female | 82 | 2024 | 382129 | 0.580 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 890 | 0.580 |
Why?
|
Drug Therapy, Combination | 4 | 2023 | 6459 | 0.570 |
Why?
|
Mitral Valve | 9 | 2024 | 1459 | 0.570 |
Why?
|
Myocardial Revascularization | 5 | 2023 | 832 | 0.570 |
Why?
|
Lower Extremity | 3 | 2023 | 1177 | 0.570 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 442 | 0.570 |
Why?
|
Middle Aged | 51 | 2024 | 214419 | 0.560 |
Why?
|
Carotid Artery Diseases | 1 | 2023 | 862 | 0.560 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2022 | 1598 | 0.560 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2023 | 3269 | 0.550 |
Why?
|
Aged, 80 and over | 32 | 2024 | 57552 | 0.530 |
Why?
|
Myocarditis | 1 | 2023 | 763 | 0.530 |
Why?
|
Time Factors | 24 | 2024 | 39589 | 0.520 |
Why?
|
Carotid Stenosis | 1 | 2023 | 850 | 0.520 |
Why?
|
Anemia | 2 | 2024 | 1481 | 0.500 |
Why?
|
Tachycardia, Ventricular | 1 | 2024 | 1285 | 0.500 |
Why?
|
Pulmonary Veins | 1 | 2021 | 732 | 0.500 |
Why?
|
Antiviral Agents | 4 | 2023 | 3013 | 0.500 |
Why?
|
Vaccines | 1 | 2023 | 817 | 0.490 |
Why?
|
Cardiomyopathies | 2 | 2024 | 1898 | 0.490 |
Why?
|
Administration, Oral | 6 | 2023 | 3966 | 0.490 |
Why?
|
Coronary Occlusion | 2 | 2014 | 303 | 0.480 |
Why?
|
Chest Pain | 2 | 2023 | 1093 | 0.480 |
Why?
|
Contrast Media | 4 | 2023 | 5251 | 0.480 |
Why?
|
Dyslipidemias | 1 | 2021 | 875 | 0.460 |
Why?
|
Femoral Artery | 6 | 2023 | 833 | 0.460 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1245 | 0.460 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 847 | 0.460 |
Why?
|
Patient Admission | 1 | 2021 | 1358 | 0.450 |
Why?
|
Dilatation, Pathologic | 1 | 2015 | 516 | 0.450 |
Why?
|
Predictive Value of Tests | 10 | 2024 | 15010 | 0.450 |
Why?
|
Behcet Syndrome | 1 | 2014 | 86 | 0.440 |
Why?
|
Cardiac Surgical Procedures | 3 | 2023 | 3539 | 0.440 |
Why?
|
Mortality | 4 | 2020 | 2851 | 0.440 |
Why?
|
Electrocardiography | 4 | 2022 | 6321 | 0.430 |
Why?
|
Paclitaxel | 1 | 2020 | 1678 | 0.430 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2572 | 0.430 |
Why?
|
Hypercholesterolemia | 3 | 2024 | 1146 | 0.420 |
Why?
|
Aspirin | 3 | 2023 | 3287 | 0.410 |
Why?
|
Incidence | 16 | 2023 | 20812 | 0.400 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2141 | 0.380 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1002 | 0.380 |
Why?
|
Aortic Aneurysm | 3 | 2020 | 631 | 0.370 |
Why?
|
Prosthesis Design | 6 | 2024 | 2104 | 0.370 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 11941 | 0.370 |
Why?
|
Interleukin-6 | 1 | 2020 | 3153 | 0.360 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3075 | 0.360 |
Why?
|
Radial Artery | 4 | 2020 | 194 | 0.360 |
Why?
|
Intracranial Embolism | 2 | 2021 | 189 | 0.350 |
Why?
|
Vascular Patency | 2 | 2023 | 889 | 0.330 |
Why?
|
Influenza, Human | 1 | 2020 | 1502 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 3 | 2024 | 2224 | 0.320 |
Why?
|
Brain Ischemia | 1 | 2022 | 3072 | 0.310 |
Why?
|
Thrombectomy | 3 | 2022 | 676 | 0.310 |
Why?
|
Atrial Appendage | 2 | 2022 | 288 | 0.300 |
Why?
|
Hospitals | 6 | 2023 | 3852 | 0.300 |
Why?
|
Heart Valve Diseases | 3 | 2020 | 1034 | 0.290 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2448 | 0.290 |
Why?
|
Logistic Models | 5 | 2023 | 13164 | 0.290 |
Why?
|
Aortic Valve Insufficiency | 2 | 2022 | 581 | 0.280 |
Why?
|
Vaccination | 3 | 2023 | 3282 | 0.280 |
Why?
|
Length of Stay | 8 | 2023 | 6292 | 0.280 |
Why?
|
Dementia | 1 | 2021 | 2545 | 0.280 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2022 | 613 | 0.270 |
Why?
|
Blood Coagulation | 2 | 2023 | 1138 | 0.270 |
Why?
|
Biphenyl Compounds | 2 | 2021 | 943 | 0.270 |
Why?
|
Lung | 2 | 2022 | 9843 | 0.260 |
Why?
|
Ventricular Function, Left | 6 | 2023 | 3704 | 0.260 |
Why?
|
Tissue Plasminogen Activator | 2 | 2022 | 1153 | 0.260 |
Why?
|
Palliative Care | 1 | 2020 | 3546 | 0.250 |
Why?
|
Follow-Up Studies | 10 | 2022 | 38752 | 0.250 |
Why?
|
Sternotomy | 2 | 2022 | 124 | 0.240 |
Why?
|
Pandemics | 6 | 2022 | 8434 | 0.240 |
Why?
|
Cardiomyopathy, Restrictive | 2 | 2022 | 62 | 0.240 |
Why?
|
Prognosis | 11 | 2024 | 29072 | 0.240 |
Why?
|
Comorbidity | 8 | 2024 | 10348 | 0.230 |
Why?
|
Prospective Studies | 11 | 2023 | 53219 | 0.230 |
Why?
|
Adult | 29 | 2024 | 214969 | 0.230 |
Why?
|
Limb Salvage | 2 | 2023 | 458 | 0.230 |
Why?
|
Echocardiography | 3 | 2023 | 4909 | 0.230 |
Why?
|
Severity of Illness Index | 11 | 2024 | 15539 | 0.220 |
Why?
|
Pacemaker, Artificial | 3 | 2024 | 807 | 0.220 |
Why?
|
Empyema, Pleural | 1 | 2023 | 61 | 0.220 |
Why?
|
Tomography, X-Ray Computed | 7 | 2024 | 20145 | 0.220 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2024 | 855 | 0.210 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7272 | 0.210 |
Why?
|
Endarterectomy | 1 | 2023 | 195 | 0.210 |
Why?
|
Plaque, Atherosclerotic | 2 | 2024 | 1487 | 0.210 |
Why?
|
United States | 15 | 2024 | 70368 | 0.200 |
Why?
|
Famotidine | 1 | 2021 | 17 | 0.200 |
Why?
|
Heart Septum | 1 | 2023 | 294 | 0.200 |
Why?
|
Bacillus | 1 | 2022 | 78 | 0.200 |
Why?
|
Weather | 2 | 2020 | 224 | 0.200 |
Why?
|
Bradycardia | 1 | 2023 | 297 | 0.200 |
Why?
|
Embolic Protection Devices | 1 | 2021 | 41 | 0.200 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2021 | 16 | 0.190 |
Why?
|
Natriuretic Peptides | 1 | 2022 | 151 | 0.190 |
Why?
|
Hypothermia | 1 | 2022 | 181 | 0.190 |
Why?
|
Neoplasms | 4 | 2023 | 21681 | 0.190 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2022 | 117 | 0.190 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2021 | 95 | 0.190 |
Why?
|
Administration, Inhalation | 2 | 2021 | 1140 | 0.190 |
Why?
|
Aorta, Thoracic | 2 | 2024 | 1050 | 0.190 |
Why?
|
Conjunctivitis, Viral | 1 | 2020 | 7 | 0.190 |
Why?
|
Marfan Syndrome | 1 | 2022 | 228 | 0.180 |
Why?
|
Cardiovascular Diseases | 4 | 2021 | 15306 | 0.180 |
Why?
|
Perindopril | 1 | 2020 | 13 | 0.180 |
Why?
|
Pleural Effusion | 1 | 2023 | 337 | 0.180 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2022 | 235 | 0.180 |
Why?
|
Odds Ratio | 3 | 2021 | 9596 | 0.180 |
Why?
|
Wind | 1 | 2019 | 40 | 0.170 |
Why?
|
Cause of Death | 5 | 2021 | 3615 | 0.170 |
Why?
|
Propensity Score | 6 | 2022 | 1848 | 0.170 |
Why?
|
Hypothermia, Induced | 2 | 2022 | 751 | 0.170 |
Why?
|
Prosthesis Failure | 2 | 2023 | 1204 | 0.170 |
Why?
|
Disease Progression | 4 | 2022 | 13302 | 0.170 |
Why?
|
Obesity | 1 | 2021 | 12670 | 0.170 |
Why?
|
Hospitals, Community | 1 | 2022 | 359 | 0.170 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.170 |
Why?
|
Postoperative Hemorrhage | 2 | 2019 | 400 | 0.160 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12018 | 0.160 |
Why?
|
Recreation | 1 | 2019 | 121 | 0.160 |
Why?
|
Albuterol | 1 | 2020 | 209 | 0.160 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2021 | 339 | 0.160 |
Why?
|
Risk | 2 | 2022 | 9521 | 0.160 |
Why?
|
Carotid Arteries | 1 | 2023 | 932 | 0.160 |
Why?
|
Renin-Angiotensin System | 2 | 2021 | 741 | 0.160 |
Why?
|
Immunization, Passive | 1 | 2021 | 612 | 0.160 |
Why?
|
Recurrence | 3 | 2024 | 8373 | 0.160 |
Why?
|
Eggs | 1 | 2020 | 183 | 0.160 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2020 | 212 | 0.160 |
Why?
|
Critical Illness | 2 | 2021 | 2690 | 0.160 |
Why?
|
Vasodilator Agents | 1 | 2023 | 961 | 0.160 |
Why?
|
Advance Directives | 1 | 2020 | 248 | 0.160 |
Why?
|
Tissue and Organ Harvesting | 1 | 2021 | 366 | 0.160 |
Why?
|
Peptide Fragments | 2 | 2022 | 5031 | 0.150 |
Why?
|
Surgical Instruments | 1 | 2020 | 389 | 0.150 |
Why?
|
Marriage | 1 | 2019 | 339 | 0.150 |
Why?
|
Medicare | 3 | 2024 | 6541 | 0.150 |
Why?
|
Titanium | 1 | 2020 | 474 | 0.150 |
Why?
|
Policy | 1 | 2022 | 502 | 0.150 |
Why?
|
Drug Combinations | 2 | 2021 | 1957 | 0.150 |
Why?
|
Gadolinium | 1 | 2023 | 945 | 0.150 |
Why?
|
Area Under Curve | 1 | 2022 | 1601 | 0.150 |
Why?
|
Survival Rate | 6 | 2021 | 12632 | 0.150 |
Why?
|
Atherosclerosis | 2 | 2024 | 3416 | 0.150 |
Why?
|
Adolescent | 8 | 2024 | 86212 | 0.150 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1442 | 0.150 |
Why?
|
Mycoses | 1 | 2020 | 383 | 0.150 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 388 | 0.150 |
Why?
|
Coronary Vasospasm | 1 | 2017 | 83 | 0.150 |
Why?
|
Popliteal Artery | 1 | 2019 | 312 | 0.140 |
Why?
|
Catheters | 2 | 2017 | 423 | 0.140 |
Why?
|
Mitral Valve Stenosis | 1 | 2019 | 340 | 0.140 |
Why?
|
Tachycardia, Supraventricular | 1 | 2019 | 270 | 0.140 |
Why?
|
Age Factors | 7 | 2024 | 18145 | 0.140 |
Why?
|
Risk Adjustment | 1 | 2021 | 596 | 0.140 |
Why?
|
Heart Ventricles | 2 | 2020 | 3772 | 0.140 |
Why?
|
Extremities | 1 | 2022 | 849 | 0.140 |
Why?
|
Pericarditis | 1 | 2018 | 134 | 0.140 |
Why?
|
Ethanol | 1 | 2023 | 1316 | 0.140 |
Why?
|
Television | 1 | 2019 | 404 | 0.140 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 512 | 0.140 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2021 | 394 | 0.140 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 1666 | 0.140 |
Why?
|
Sarcoidosis | 1 | 2022 | 513 | 0.130 |
Why?
|
Intracranial Hemorrhages | 1 | 2022 | 836 | 0.130 |
Why?
|
Spironolactone | 1 | 2020 | 398 | 0.130 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2022 | 529 | 0.130 |
Why?
|
Tricuspid Valve | 1 | 2019 | 402 | 0.130 |
Why?
|
Aromatase Inhibitors | 1 | 2020 | 509 | 0.130 |
Why?
|
Geriatric Assessment | 1 | 2023 | 1365 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2023 | 857 | 0.130 |
Why?
|
Cold Temperature | 1 | 2019 | 761 | 0.130 |
Why?
|
Renal Insufficiency | 1 | 2021 | 786 | 0.130 |
Why?
|
Kidney Transplantation | 2 | 2021 | 4091 | 0.130 |
Why?
|
Prevalence | 9 | 2024 | 15306 | 0.130 |
Why?
|
Body Mass Index | 4 | 2022 | 12633 | 0.130 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 581 | 0.130 |
Why?
|
Coronary Stenosis | 1 | 2022 | 814 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 823 | 0.130 |
Why?
|
Comprehension | 1 | 2021 | 606 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1060 | 0.130 |
Why?
|
Bacteremia | 1 | 2022 | 967 | 0.130 |
Why?
|
Amyloidosis | 1 | 2022 | 803 | 0.120 |
Why?
|
Hemodynamics | 3 | 2020 | 4187 | 0.120 |
Why?
|
Medical Records | 1 | 2020 | 1389 | 0.120 |
Why?
|
Child | 5 | 2023 | 78469 | 0.120 |
Why?
|
Sex Factors | 3 | 2024 | 10278 | 0.120 |
Why?
|
Lactic Acid | 1 | 2020 | 1118 | 0.120 |
Why?
|
Benzimidazoles | 1 | 2020 | 857 | 0.120 |
Why?
|
Gait | 1 | 2020 | 799 | 0.120 |
Why?
|
Patient Discharge | 3 | 2022 | 3304 | 0.120 |
Why?
|
Tetrazoles | 1 | 2020 | 861 | 0.120 |
Why?
|
Hot Temperature | 1 | 2020 | 1415 | 0.110 |
Why?
|
Robotics | 1 | 2021 | 879 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 1003 | 0.110 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12272 | 0.110 |
Why?
|
Heart Atria | 2 | 2023 | 1321 | 0.110 |
Why?
|
Anticholesteremic Agents | 1 | 2021 | 981 | 0.110 |
Why?
|
Fontan Procedure | 1 | 2019 | 786 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2021 | 1027 | 0.110 |
Why?
|
Arterio-Arterial Fistula | 1 | 2013 | 20 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2043 | 0.110 |
Why?
|
Calcium | 2 | 2023 | 5654 | 0.110 |
Why?
|
Sulfonamides | 1 | 2023 | 1949 | 0.110 |
Why?
|
Creatinine | 1 | 2018 | 1848 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1367 | 0.110 |
Why?
|
Bone Density Conservation Agents | 1 | 2020 | 779 | 0.110 |
Why?
|
Forecasting | 1 | 2022 | 2906 | 0.110 |
Why?
|
Azathioprine | 1 | 2014 | 352 | 0.110 |
Why?
|
Cerebrovascular Disorders | 1 | 2019 | 1484 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2022 | 2117 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1395 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4858 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1158 | 0.100 |
Why?
|
Cohort Studies | 5 | 2024 | 40505 | 0.100 |
Why?
|
Glucose | 1 | 2024 | 4303 | 0.100 |
Why?
|
Coronary Thrombosis | 1 | 2015 | 485 | 0.100 |
Why?
|
Social Class | 1 | 2020 | 1966 | 0.100 |
Why?
|
Endoscopy | 1 | 2021 | 1829 | 0.100 |
Why?
|
Hepatitis C | 1 | 2021 | 1588 | 0.100 |
Why?
|
Young Adult | 6 | 2024 | 57114 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2142 | 0.090 |
Why?
|
Survival Analysis | 2 | 2020 | 10127 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5093 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3695 | 0.090 |
Why?
|
Osteoporosis | 1 | 2020 | 1581 | 0.090 |
Why?
|
Feeding Behavior | 2 | 2020 | 3156 | 0.090 |
Why?
|
Immunosuppressive Agents | 3 | 2022 | 4055 | 0.090 |
Why?
|
Intracranial Aneurysm | 1 | 2019 | 1206 | 0.090 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 340 | 0.090 |
Why?
|
Pulmonary Artery | 2 | 2022 | 1919 | 0.090 |
Why?
|
Heart | 1 | 2022 | 4361 | 0.080 |
Why?
|
Prednisone | 1 | 2014 | 1557 | 0.080 |
Why?
|
Parents | 1 | 2023 | 3462 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2476 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1758 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2024 | 4287 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2020 | 2204 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 1875 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2512 | 0.080 |
Why?
|
Tissue Donors | 3 | 2022 | 2206 | 0.080 |
Why?
|
Reoperation | 3 | 2024 | 4215 | 0.080 |
Why?
|
Graft Rejection | 4 | 2022 | 4203 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3751 | 0.080 |
Why?
|
Inflammation | 2 | 2020 | 10591 | 0.080 |
Why?
|
Cities | 2 | 2020 | 523 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2021 | 3669 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2023 | 12742 | 0.070 |
Why?
|
Models, Statistical | 1 | 2022 | 5027 | 0.070 |
Why?
|
Bone Density | 1 | 2020 | 3510 | 0.070 |
Why?
|
Pain | 1 | 2022 | 4980 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7673 | 0.070 |
Why?
|
Heart Defects, Congenital | 2 | 2020 | 4657 | 0.070 |
Why?
|
Temperature | 2 | 2022 | 2191 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3136 | 0.070 |
Why?
|
Research Design | 1 | 2022 | 6056 | 0.070 |
Why?
|
Sepsis | 1 | 2020 | 2589 | 0.060 |
Why?
|
Kidney | 1 | 2021 | 6984 | 0.060 |
Why?
|
Child, Preschool | 3 | 2023 | 41383 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3204 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4578 | 0.060 |
Why?
|
Postoperative Period | 2 | 2020 | 1804 | 0.060 |
Why?
|
Angiography | 2 | 2024 | 1596 | 0.060 |
Why?
|
Ischemia | 2 | 2023 | 1857 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2020 | 4558 | 0.050 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1384 | 0.050 |
Why?
|
Corn Oil | 1 | 2022 | 30 | 0.050 |
Why?
|
Mineral Oil | 1 | 2022 | 24 | 0.050 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 73 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5280 | 0.050 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2023 | 325 | 0.050 |
Why?
|
Endoleak | 1 | 2022 | 102 | 0.050 |
Why?
|
Deoxyribonucleases | 1 | 2023 | 213 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6109 | 0.050 |
Why?
|
Equipment Design | 2 | 2024 | 3509 | 0.050 |
Why?
|
Aorta, Abdominal | 1 | 2024 | 599 | 0.050 |
Why?
|
Graft Survival | 2 | 2022 | 3599 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4639 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29296 | 0.050 |
Why?
|
Ultrasonography | 1 | 2014 | 5895 | 0.050 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2021 | 142 | 0.050 |
Why?
|
Ramipril | 1 | 2021 | 96 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 387 | 0.050 |
Why?
|
Regression Analysis | 2 | 2020 | 6332 | 0.050 |
Why?
|
Gram-Negative Bacteria | 1 | 2022 | 264 | 0.050 |
Why?
|
Intermittent Claudication | 1 | 2023 | 304 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13531 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1086 | 0.040 |
Why?
|
Thoracotomy | 1 | 2021 | 358 | 0.040 |
Why?
|
Heart-Lung Transplantation | 1 | 2020 | 84 | 0.040 |
Why?
|
Acute Disease | 2 | 2021 | 7116 | 0.040 |
Why?
|
Antilymphocyte Serum | 1 | 2021 | 474 | 0.040 |
Why?
|
Enalapril | 1 | 2021 | 327 | 0.040 |
Why?
|
Fee-for-Service Plans | 1 | 2024 | 681 | 0.040 |
Why?
|
Septal Occluder Device | 1 | 2020 | 131 | 0.040 |
Why?
|
Waiting Lists | 1 | 2023 | 716 | 0.040 |
Why?
|
Debridement | 1 | 2021 | 494 | 0.040 |
Why?
|
Coma | 1 | 2022 | 483 | 0.040 |
Why?
|
Brain Death | 1 | 2022 | 340 | 0.040 |
Why?
|
Perioperative Period | 1 | 2020 | 254 | 0.040 |
Why?
|
Neprilysin | 1 | 2021 | 448 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 411 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1337 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2022 | 603 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1113 | 0.040 |
Why?
|
No-Reflow Phenomenon | 1 | 2017 | 16 | 0.040 |
Why?
|
Databases, Factual | 2 | 2024 | 7812 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1795 | 0.040 |
Why?
|
Cattle | 1 | 2023 | 3839 | 0.040 |
Why?
|
Reference Standards | 1 | 2020 | 1001 | 0.040 |
Why?
|
Prostheses and Implants | 1 | 2023 | 1270 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13196 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 565 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16250 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2023 | 904 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2021 | 1789 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 892 | 0.030 |
Why?
|
Fever | 1 | 2022 | 1604 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2020 | 869 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.030 |
Why?
|
Sirolimus | 1 | 2022 | 1529 | 0.030 |
Why?
|
Hospital Costs | 1 | 2021 | 958 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1735 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1656 | 0.030 |
Why?
|
Protein Precursors | 1 | 2018 | 1124 | 0.030 |
Why?
|
Hepacivirus | 1 | 2021 | 1364 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 810 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2023 | 2370 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1125 | 0.030 |
Why?
|
Abdomen | 1 | 2020 | 1104 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2172 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7223 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4617 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 1223 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20754 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2713 | 0.030 |
Why?
|
Collateral Circulation | 1 | 2013 | 276 | 0.030 |
Why?
|
Income | 1 | 2020 | 1852 | 0.020 |
Why?
|
Liver Diseases | 1 | 2020 | 1268 | 0.020 |
Why?
|
Perioperative Care | 1 | 2019 | 998 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2558 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 12985 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4115 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 35781 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12839 | 0.020 |
Why?
|
Lung Diseases | 1 | 2020 | 1894 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2924 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3324 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2020 | 2068 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10719 | 0.020 |
Why?
|
Angina, Unstable | 1 | 2013 | 917 | 0.020 |
Why?
|
Infant | 2 | 2020 | 35448 | 0.020 |
Why?
|
Coronary Circulation | 1 | 2013 | 1559 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14114 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7935 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 974 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12775 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19804 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9172 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6939 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21676 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11539 | 0.010 |
Why?
|
Animals | 1 | 2023 | 166308 | 0.010 |
Why?
|